 |
Articles: M&A/Partnerships |
License Agreement with Romark Laboratories and Development of Nitazoxanide in Japan
Chugai Pharmaceutical Co., 04/02/09
Free full text
Bayer HealthCare and Genzyme Corporation Enter New Strategic Agreement
BayNews International, 04/01/09
Free full text
Genzyme and Bayer HealthCare Enter New Strategic Agreement
Genzyme, 04/01/09
Free full text
Ottawa-area hospital acquires advanced DI systems
Canadian Healthcare Technology, 04/01/09
Free full text
APP Pharmaceuticals Announces Trading Information on NASDAQ of Contingent Value Rights Associated with the Acquisition by Fresenius
American Pharmaceutical Partners, 03/31/09
Free full text
Bayer MaterialScience sells Thermoplastics Testing Center to Underwriters Laboratories
BayNews International, 03/31/09
Free full text
Alcon Signs Contract with LCA-Vision for 75 ALLEGRETTO WAVE(R) Excimer Lasers
Alcon, 03/30/09 License Agreement with Romark Laboratories and Development of Nitazoxanide in Japan
Chugai Pharmaceutical Co., 03/30/09
Free full text
Bristol-Myers Squibb to Settle Securities Class Action Litigation
Bristol Myers-Squibb Company, 03/27/09
Free full text
Roche Completes Acquisition of Genentech
Genentech, 03/27/09
Free full text
License Agreement with Romark Laboratories and Development of Nitazoxanide in Japan
Chugai Pharmaceutical Co., 03/27/09
Free full text
Human genome sciences and morphoteka, inc. announce collaboration to discover, develop and commercialize antibodies for oncology and immunology
Human Genome Sciences, 03/26/09
Free full text
Bristol-Myers Squibb Foundation and China Foundation for Hepatitis Prevention and Control Collaborate to Fight One of Chinas Most Pressing Health Problems
Bristol Myers-Squibb Company, 03/26/09
Free full text
Public/Private Partnerships To Help Determine Clinical Biomarker Utility
Applied Clinical Trials, 03/24/09
Free full text
Array BioPharma Accelerates Partnering Activities and Scales Back Discovery Research to Extend Available Capital
Array BioPharma, 03/24/09
Free full text
Merck Provides Update on Merger Financing
Merck & Co., 03/24/09
Free full text
License Agreement with Romark Laboratories and Development of Nitazoxanide in Japan
Chugai Pharmaceutical Co., 03/24/09
Free full text
Morphotek, Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
Morphotek, 03/24/09
Free full text
Teva and Medicis Announce Settlement Agreement
Teva Pharmaceutical Industries, 03/23/09
Free full text
License Agreement with Romark Laboratories and Development of Nitazoxanide in Japan
Chugai Pharmaceutical Co., 03/23/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
